At PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS), Share Price Got a Bit Ahead of the Fundamentals
PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS) Relative Strength Index (RSI) is 68.14, with weekly volatility at 6.12% and ATR at 0.23. The PHAS stock’s 52-week price range